InvestorsHub Logo
Followers 66
Posts 1631
Boards Moderated 0
Alias Born 01/31/2014

Re: PharmD08 post# 80481

Monday, 10/24/2016 8:10:43 PM

Monday, October 24, 2016 8:10:43 PM

Post# of 721897
Yes the price was $0.38/sh.

Some may have a bad taste with a 30% price discount, but consider what is normal or somewhat common in a biotech financing: 15% discount + 15% coverage of free warrants to the buyer. To me the decision by LP to trade a cash discount instead of giving warrant coverage, means she believes the shares will be worth much more than the incremental 15% discount (~$1M cash impact)prior to the next financing is to occur. I take that is an expression of confidence. How much more we shall see.

For shorts, I imagine their hope was a financing to a shareholder that sells in the marketplace and helps them cover because currently I don't see anyone will sell in great quantities. Given NWBO's fight against the wolf pack and the overtime howls of some posters here, I suspect that indeed did not happen. Instead, NWBO has $5M in cash, added a new friendly long term investor (tbd), and is about to release Phase 3 results that LP is confident will be positive, IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News